Bizarre Patents
A Receptacle for supporting, rotating and sculpting a portion of ice cream or similarly malleable food while it is being consumed.
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 8168597 | Method for treating cystic fibrosis The present invention is directed to a method for treating cystic fibrosis. The method comprises the steps of: identifying a patient suffering from cystic fibrosis, and administering to the patient an effective amount of denufosol or a pharmaceutically acceptable sa... | 05/01/2012 |
| 8158796 | Process for the preparation of Rho-kinase inhibitor compounds The present invention is directed to practical high-yielding synthetic processes to prepare compounds of general Formula III, IV, V, VII, VIII, IX, X, XII, XIV, and XV. Such compounds are useful as final products or can be used as intermediates and be further modifi... | 04/17/2012 |
| 8158776 | P2Yreceptor agonists for treating lung diseases This invention is directed to a method of enhancing or facilitating the clearance or the lung mucus secretions in a subject. This invention is also directed to a method of facilitating the hydration of the lung mucus secretions in a subject. This invention is furthe... | 04/17/2012 |
| 8147843 | CD95L or trail fusion proteins The present invention refers to fusion proteins comprising a TNF superfamily (TNFSF) cytokine or a receptor binding domain thereof fused to a trimerization domain and a nucleic acid molecule encoding the fusion protein. The fusion protein is present as a trimeric co... | 04/03/2012 |
| 8124419 | Gas sensor devices comprising organized carbon and non-carbon assembly This invention relates generally to gas sensors comprising organized assemblies of carbon and non-carbon compounds. The invention also relates to devices containing such gas sensors and analysis units. In preferred embodiments, the organized assemblies of the instan... | 02/28/2012 |
| 8097600 | Method of increasing tear production with purinergic receptor agonists A method and preparation for the stimulation of tear secretion in a subject in need of such treatment is disclosed. The method comprises administering to the ocular surfaces of the subject a purinergic receptor agonist such as uridine 5′-triphosphate (UTP), dinucl... | 01/17/2012 |
| 8071779 | Cytoskeletal active rho kinase inhibitor compounds, composition and use The present invention is directed to synthetic cytoskeletal active compounds that are inhibitors of rho-associated protein kinase. The present invention is also directed to pharmaceutical compositions comprising such compounds and a pharmaceutically acceptable carri... | 12/06/2011 |
| 8053552 | Neopeptides and methods useful for detection and treatment of cancer The present invention relates to compounds and methods useful for the detection and treatment of disorders associated with frameshift mutations in coding microsatellite regions. The compounds and methods are applicable in cancers, especially of DNA mismatch repair d... | 11/08/2011 |
| 8039465 | Cytoskeletal active compounds, composition and use The present invention is directed to synthetic cytoskeletal active compounds that are related to natural Latrunculin A or Latrunculin B. The present invention is also directed to pharmaceutical compositions comprising such compounds and a pharmaceutically acceptable... | 10/18/2011 |
| 8023071 | Transmissive or reflective liquid crystal display This invention relates to a liquid crystal display with improved contrast ratio, switching performance, reflectivity at the Dmin state and structural integrity, and methods for its manufacture. The liquid crystal display of the present invention comprises microcups ... | 09/20/2011 |
| 8008274 | P1-(2′-deoxycytidine 5′-)P4-(uridine 5′-)tetraphosphate, tetra-(alkali metal) salt, for treating sinusitis The present invention provides a method of treating edematous retinal disorders. The method comprises administration of a pharmaceutical formulation comprising a hydrolysis-resistant P2Y receptor agonist to stimulate the removal of pathological extraneous fluid from... | 08/30/2011 |
| 8007813 | CD95-Fc fusion proteins The invention relates to fusion proteins comprising at least a first domain and a second domain selected from a constant Fc immunoglobulin domain. ... | 08/30/2011 |
| 8003696 | Composition and method for treating bacterial, viral, fungal diseases, inflammation and pain The present invention is directed to compositions and methods of treating bacterial, viral, fungal diseases; inflammation or inflammatory-related disorders; pain; and skin conditions. The composition comprises an organic solvent extract, which is prepared by the met... | 08/23/2011 |
| 8003599 | Inhibitors of L1 and ADAM10 for the treatment of carcinomas Described is a pharmaceutical composition comprising a compound(s) interfering with the biological activity of L1 and/or ADAM10 or their expression. Also described is the use of said compound(s) for the prevention/treatment of carcinomas like ovarian and endometrial... | 08/23/2011 |
| 7989010 | Method of reducing off-flavor in a beverage using silane-treated silica filter media The present invention provides a method for preventing or reducing off-flavor in a beverage. Silane-treated silica filter media are synthesized. By contacting the beverage with the silane-treated silica filter, one or more off-flavor substances or off-flavor precurs... | 08/02/2011 |
| 7982000 | Composition comprising various proteorhodopsins and/or bacteriorhodopsins and use thereof The present invention provides a solid material comprising an immobilized mixture of two or more proteorhodopsins, two or more bacteriorhodopsins, or one or more bacteriorhodopsin and one or more proteorhodopsins. The proteorhodopsins are selected from the group con... | 07/19/2011 |
| 7977307 | Method for reducing pain with ziconotide and morphine The present invention is direct to a method of producing analgesia in a mammalian subject. The method includes administering to the subject an omega conopeptide, preferably ziconotide, in combination with an analgesic selected from the group consisting of morphine, ... | 07/12/2011 |
| 7956030 | Method for reducing pain with ziconotide and baclofen The present invention is direct to a method of producing analgesia in a mammalian subject. The method includes administering to the subject an omega conopeptide, preferably ziconotide, in combination with an analgesic selected from the group consisting of morphine, ... | 06/07/2011 |
| 7955532 | High performance capsules for electrophoretic displays The present invention is directed to novel non-aqueous capsules suitable as display cells for an electrophoretic display and the encapsulation process for their manufacture. The present invention is also directed to an encapsulation process for the preparation of no... | 06/07/2011 |
| 7947850 | Process for the preparation of 3,4-disubstituted-thiazolidin-2-ones The present invention is directed to practical high-yielding synthetic processes for preparing 3,4-disubstituted-thiazolidin-2-ones, which do not compromise the absolute stereochemical integrity of the compounds. The present invention is also directed to novel compo... | 05/24/2011 |
| 7943760 | Non-nucleotide composition for inhibiting platelet aggregation This invention is directed to a method of preventing or treating diseases or conditions associated with platelet aggregation. The method is also directed to a method of treating thrombosis or related disorders. The method comprises administering to a subject a pharm... | 05/17/2011 |
| 7943238 | Capacitors comprising organized assemblies of carbon and non-carbon compounds This invention relates generally to capacitors comprising organized assemblies of carbon and non-carbon compounds. This invention further relates to methods of making such organized structures. It also relates to devices containing such structures. In preferred embo... | 05/17/2011 |
| 7939510 | Di(uridine 5′-)tetraphosphate and salts thereof The present invention are directed to P1,P4-di(uridine 5′-)tetraphosphate, tetra-alkali metal salts such as tetrasodium, tetralithium, tetrapotassium, and mixed tetra-alkali metal cations thereof. The tetra alkali metal salts of P1... | 05/10/2011 |
| 7938987 | Organized carbon and non-carbon assembly and methods of making This invention relates generally to organized assemblies of carbon and non-carbon compounds and methods of making such organized structures. In preferred embodiments, the organized structures of the instant invention take the form of nanorods or their aggregate form... | 05/10/2011 |
| 7932376 | Pyrimidine-based non-nucleotide composition and method for inhibiting platelet aggregation This invention is directed to a method of preventing or treating diseases or conditions associated with platelet aggregation. The method is also directed to a method of treating thrombosis or related disorders. The method comprises administering to a subject a pharm... | 04/26/2011 |
| 7932047 | Method for detecting neoplastic disorders in a solubilized body sample The present invention relates to a method for the early diagnosis of neoplastic disorders such as cancers as well as their precursor stages, particularly cancers of the respiratory tract, the urinary system, the reproductive tract, cancer associated with HPV infecti... | 04/26/2011 |
| 7927819 | Method for stabilization of proteins in solution The present invention relates to a method for stabilization of analytes in solutions of solubilized body samples. The method comprises the steps of solubilizing the body samples obtained from a subject in a suitable sample medium and stabilizing said body sample con... | 04/19/2011 |
| 7901677 | Use of an antibody against the laminin receptor or laminin receptor precursor for the treatment or diagnosis of several cancer types Described is the use of a recombinant antibody comprising a binding site specific for an epitope of the laminin receptor or laminin receptor precursor for the treatment or diagnosis of various cancers, particularly B-CLL. Preferably, this antibody additionally compr... | 03/08/2011 |
| 7883896 | Marker molecules associated with lung tumors The present invention relates to nucleic acids and polypeptides associated with lung cancer. The invention is more specifically related to a nucleic acids and the polypeptides transcribed thereof, the expression of which is significantly altered in association with ... | 02/08/2011 |
| 7851650 | Compounds for treating inflammation and pain The present invention is directed to a compound of 2-N halo-4-methylsulfonyl-butyric acid, such as 2-N chloro-4-methylsulfonyl-butyric acid, or a pharmaceutically acceptable salt or solvate thereof. The present invention is also directed to a pharmaceutical composit... | 12/14/2010 |
| 7851456 | P2Y6 receptor agonists for treating lung diseases This invention is directed to a method of enhancing or facilitating the clearance of the lung mucus secretions in a subject. This invention is also directed to a method of facilitating the hydration of the lung mucus secretions in a subject. This invention is furthe... | 12/14/2010 |
| 7851182 | Soluble GP130 molecule variants useful as a medicament A polypeptide-dimer built of two identical monomeric fragments comprising the domains 1 to 3 of the extracellular (soluble) part of glycoprotein (gp)130 and a certain polypeptide spacer are described, which are covalently linked with each other and which bear signif... | 12/14/2010 |
| 7850012 | Silane-treated silica filter media The present invention provides methods for separating one or more components of interest from a sample containing particulates and soluble materials. The method comprises the steps of: (a) filtering a sample through silica filter media whose surface silanol groups h... | 12/14/2010 |
| 7833973 | Pharmaceutical formulations for reducing pain The present invention is direct to a method of producing analgesia in a mammalian subject. The method includes administering to the subject an omega conopeptide, preferably ziconotide, in combination with an analgesic selected from the group consisting of morphine, ... | 11/16/2010 |
| 7800813 | Methods and compositions for improved electrophoretic display performance The invention is directed to novel methods and compositions useful for improving the performance of electrophoretic displays. The methods comprise adding a high absorbance dye or pigment, or conductive particles, or a conductive filler in the form of nanoparticles a... | 09/21/2010 |
| 7794840 | Capacitors comprising organized assemblies of carbon and non-carbon compounds This invention relates generally to capacitors comprising organized assemblies of carbon and non-carbon compounds. This invention further relates to methods of making such organized structures. It also relates to devices containing such structures. In preferred embo... | 09/14/2010 |
| 7785624 | Pharmaceutical latrunculin formulations The present invention relates to an aqueous pharmaceutical formulation comprising at least one latrunculin and the formulation does not contain a substantial amount of dimethyl sulfoxide. In one embodiment, the present invention is directed to an aqueous pharmaceuti... | 08/31/2010 |
| 7767719 | Anthracenedione compounds This invention relates compositions containing compounds of formula (I) below: Each of R1, R2, R3, R4, R5, R6, R7, and R8 is defined in t... | 08/03/2010 |
| 7759382 | Acylated amino acid amidyl pyrazoles and related compounds This invention is directed to acylated amino acid amidyl pyrazoles and related compounds of Formula I. The invention is also directed to a pharmaceutical formation comprising such compound or in a pharmaceutically acceptable salt form thereof. The invention is furth... | 07/20/2010 |
| 7754751 | Preferential inhibition of release of pro-inflammatory cytokines A method for preferentially inhibiting release of pro-inflammatory cytokines over release of anti-inflammatory cytokines using a fused pyrazolyl compound of formula (I): A is R or ... | 07/13/2010 |
